| SQSTM1/p62: a potential target for neurodegenerative disease S Ma, IY Attarwala, XQ Xie ACS chemical neuroscience 10 (5), 2094-2114, 2019 | 123 | 2019 |
| Discovery of novel ligands for TNF-α and TNF receptor-1 through structure-based virtual screening and biological assay S Chen, Z Feng, Y Wang, S Ma, Z Hu, P Yang, Y Chai, X Xie Journal of chemical information and modeling 57 (5), 1101-1111, 2017 | 64 | 2017 |
| Cardiovascular disease chemogenomics knowledgebase-guided target identification and drug synergy mechanism study of an herbal formula H Zhang, S Ma, Z Feng, D Wang, C Li, Y Cao, X Chen, A Liu, Z Zhu, ... Scientific reports 6 (1), 33963, 2016 | 39 | 2016 |
| Allosteric binding site and activation mechanism of class C G-protein coupled receptors: metabotropic glutamate receptor family Z Feng, S Ma, G Hu, XQ Xie The AAPS journal 17, 737-753, 2015 | 38 | 2015 |
| Computational advances for the development of allosteric modulators and bitopic ligands in G protein-coupled receptors Z Feng, G Hu, S Ma, XQ Xie The AAPS journal 17 (5), 1080-1095, 2015 | 36 | 2015 |
| Prediction of orthosteric and allosteric regulations on cannabinoid receptors using supervised machine learning classifiers Y Bian, Y Jing, L Wang, S Ma, JJ Jun, XQ Xie Molecular pharmaceutics 16 (6), 2605-2615, 2019 | 35 | 2019 |
| Difference and influence of inactive and active states of cannabinoid receptor subtype CB2: from conformation to drug discovery J Hu, Z Feng, S Ma, Y Zhang, Q Tong, MH Alqarni, X Gou, XQ Xie Journal of chemical information and modeling 56 (6), 1152-1163, 2016 | 32 | 2016 |
| Chemogenomics knowledgebase and systems pharmacology for hallucinogen target identification—Salvinorin A as a case study X Xu, S Ma, Z Feng, G Hu, L Wang, XQ Xie Journal of Molecular Graphics and Modelling 70, 284-295, 2016 | 25 | 2016 |
| Multi-functional diarylurea small molecule inhibitors of TRPV1 with therapeutic potential for neuroinflammation Z Feng, LV Pearce, Y Zhang, C Xing, BKA Herold, S Ma, Z Hu, NA Turcios, ... The AAPS journal 18, 898-913, 2016 | 23 | 2016 |
| Synergism of antihypertensives and cholinesterase inhibitors in Alzheimer's disease Z Hu, L Wang, S Ma, L Kirisci, Z Feng, Y Xue, WE Klunk, MI Kamboh, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 4 …, 2018 | 13 | 2018 |
| Chemogenomics systems pharmacology mapping of potential drug targets for treatment of traumatic brain injury L Wang, S Ma, Z Hu, TF McGuire, XQ Xie Journal of Neurotrauma 36 (4), 565-575, 2019 | 7 | 2019 |
| The influence of calculated physicochemical properties of compounds on their ADMET profiles S Ma, M McGann, IJ Enyedy Bioorganic & Medicinal Chemistry Letters 36, 127825, 2021 | 2 | 2021 |
| Chemogenomics analysis of drug targets for the treatment of acute promyelocytic leukemia S Chen, X Li, S Ma, X Xing, X Wang, Z Zhu Annals of hematology 99, 753-763, 2020 | 2 | 2020 |
| Use of Solvent Mapping for Characterizing the Binding Site and for Predicting the Inhibition of the Human Ether-á-Go-Go-Related K+ Channel S Ma, Z Sun, Y Jing, M McGann, S Vajda, IJ Enyedy Chemical research in toxicology 35 (8), 1359-1369, 2022 | 1 | 2022 |
| Erratum to: Computational Advances for the Development of Allosteric Modulators and Bitopic Ligands in G Protein-Coupled Receptors Z Feng, G Hu, S Ma, XQ Xie The AAPS journal 18 (6), 1585-1585, 2016 | 1 | 2016 |
| Chemogenomics Mapping of Potential Drugs and Targets for Treatment of Multiple Myeloma S Ma, XQ Xie | | 2021 |
| Design, Synthesis and Biological Evaluation of Novel P62zz Ligands with Therapeutic Potentials S Ma University of Pittsburgh, 2021 | | 2021 |
| Chemogenomics Knowledgebase and Targethunter for Polypharmacology Analysis of A Traditional Chinese Herbal Formula," Sini Decoction" S Ma University of Pittsburgh, 2015 | | 2015 |
